Zelda Therapeutics Ltd. Stock Price - ZLDAF

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
$50.99
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$60.99
SMALL CAP PRO
Monthly Subscription
for only
$44.59
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Zelda Therapeutics Ltd. (PC) ZLDAF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0 +0% 0.105 - - - 0.105 07:01:42
Bid Price Ask Price Spread Spread % News
0.099 0.115 0.016 13.91% - -
Last Trade Time Type Quantity Stock Price Currency
- - - USD

Zelda Therapeutics Ltd. (PC) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 79.26M 754.84M $ -6.16M - -12.87 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Zelda Therapeutics Ltd. (PC) News

Latest ZLDAF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZLDAF Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.0920.10950.0850.0971488k895k604k0.01314.13%
1 Month0.0750.1410.0690.102025k5M717k0.0340.00%
3 Months0.061190.1510.050.098305M259k0.0438171.60%
6 Months0.0510.1510.050.095905M125k0.054105.88%
1 Year0.040.1510.040.091205M103k0.065162.50%
3 Years0.040.1510.040.091205M103k0.065162.50%
5 Years0.040.1510.040.091205M103k0.065162.50%

Zelda Therapeutics Ltd. (PC) Description

Zelda Therapeutics ("Zelda") is an Australian-based bio-pharmaceutical company that is focused on developing a range of cannabinoid-based formulations for the treatment of a variety of medical conditions. The Company has a two-pronged strategy comprising: A human clinical trial programme focused on insomnia, autism and eczema with activities in Australia and Chile. A pre-clinical research programme examining the effect of cannabinoids in breast, brain and pancreatic cancer. It has partnered with the world's leading cancer cannabis researchers at Complutense University Madrid in Spain to conduct certain pre-clinical work testing cannabis-based formulations known to have an effect in humans in order to generate data packs in a form expected by regulators and the pharmaceutical industry. A similar programme is in place with the Australian Telethon Kids Institute targeting paediatric brain cancer and Curtin University targeting pancreatic cancer.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.